 |
|
|
| |
CROI: Neurocognitive Disorders - Neurologic, Brain, Cognitive Impairment
|
| |
| |
CROI:Cognitive Trajectories in Suppressed HIV Infection Indicate Evolving Disease Activity - (02/24/17).....57% of the cohort showed evolution of their disease, challenging the notion of neurocognitive stability in virally suppressed HIV+ persons.....despite long term viral suppression
CROI: LONGITUDINAL ASSESSMENT OF REGIONALLY SPECIFIC BRAIN VOLUMES IN TREATED HIV+ PATIENTS - (02/24/17)
CROI: IMPACT OF ADVANCING AGE ON COGNITION IN HIV+ PERSONS ON A FIRST SUPPRESSIVE REGIMEN - (02/24/17)
CROI: LONGITUDINAL ANALYSIS SHOWS NO EVIDENCE FOR ACCELERATED BRAIN AGEING IN TREATED HIV - (02/24/17)
CROI: Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression: HIV+ virally suppressed had worse cognitive decline in 3 domains vs HIV-neg, 4 yrs followup - (02/24/17)
CROI: BIOMARKERS OF AGEING IN HIV-POSITIVE INDIVIDUALS AND MATCHED CONTROLS: 8 years greater biologic age in HIV+ - (02/24/17)...."biological age was significantly greater than chronological age by 13.2 years in HIV+ and by 5.5 years in HIV-neg”
CROI: CEREBRAL SMALL-VESSEL DISEASE IN HIV-INFECTED PATIENTS WELL CONTROLLED ON CART - (03/02/17)...."prevalence of CSVD was 52% in a well controlled group of HIV+ over the age of 50 with an ORa of 2.3 compared to HIV-neg, risk factors: nadir CD4 <200, age, hypertension"
CROI: Cognitive Complaints and Development of Falls among HIV-Infected and Uninfected Women - (03/06/17)...."Cognitive complaints (self-reported major problems with memory or concentration, confusion, or inability to perform routine mental tasks) by women were associated with increased odds of having a fall..,previously reported high prevalence of falls in WIHS, 18-19% had 1 or more falls in past 6 months"
CROI: Prevalence of neurocognitive disorders in a well-treated and aging Swiss HIV Cohort - (03/29/17)....."Prevalence of HAND remains high (27%) despite that HIV infection is very well controlled...ANI (asymptomatic) is a major contributor to HAND”
CROI: Telomere length: neurocognitive biomarker in HIV-1-infected subjects - (03/02/17)
CROI:Frailty Stronger Than Neurocognitive Impairment in Predicting Falls-Disability-Death - (02/26/17)
CROI: Use of Cocaine, Meth, Opioids Remains High in US MSM: 2008-2014 - (03/30/17)
CROI: Frailty Status and Risk of Falls in HIV-Infected Older Adults in the ACTG A5322 Study - - (04/05/17)
CROI: Frailty Progression and Recovery among Persons Aging with HIV and Substance Use - (02/18/17)
WHO IS MANAGING AGING PATIENTS & THEIR RISK FOR FALLS ? No ONE - Jules Levin, NATAP - (02/09/17)
Aging of HIV-Infected: an explosive and underestimated phenomena being ignored, needs attention - special support services for patients & clinics needed-lack of federal/state response - HCV too - (04/04/17)
CROI: New HIV Drugs at CROI / CROI Antiretroviral Treatment Summary / Long Acting HIV Therapies - (03/31/17)
------------------------------------
|
| |
|
|
|
|
|
